Drugs & Targets AstraZeneca, Ibex collaborate on AI-powered HER2 scoring product January 27, 2023Vol.49 No.04
Drugs & Targets Evotec, Janssen collaborate to develop immune-based therapies January 27, 2023Vol.49 No.04
Conversation with The Cancer Letter City of Hope’s Mustafa Raoof: Medicare Advantage cancer patients more likely to die within 30 days after complex surgery January 20, 2023Vol.49 No.03By Matthew Bin Han Ong
In Brief Terrance Mayes, Loretta Erhunmwunsee named leaders of NCCN Forum on Equity January 20, 2023Vol.49 No.03
In Brief Sofia Garcia named director of Cancer Survivorship Institute at Northwestern January 20, 2023Vol.49 No.03
In Brief The Mark Foundation awards $4.5M to six early-career scientists January 20, 2023Vol.49 No.03
In Brief Gifts from Walther, Regenstrief foundations create cancer informatics chair at IU Simon January 20, 2023Vol.49 No.03
In Brief Joel Helmke named vice chair of the board of directors of the Alliance of Dedicated Cancer Centers January 20, 2023Vol.49 No.03
In Brief Andrea Wolf receives Irving J. Selikoff Lifetime Achievement Award from Asbestos Disease Awareness Organization January 20, 2023Vol.49 No.03
In Brief Jennifer Wargo receives TAMEST O’Donnell Award for pioneering microbiome research January 20, 2023Vol.49 No.03
